Viatris, Inc. (VTRS)
16.94
-0.16
(-0.91%)
USD |
NASDAQ |
Sep 03, 16:00
16.94
0.00 (0.00%)
After-Hours: 20:00
Viatris Cash from Investing (Quarterly) : -51.60M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -51.60M |
| March 31, 2026 | 277.40M |
| December 31, 2025 | -211.20M |
| September 30, 2025 | -98.90M |
| June 30, 2025 | -52.50M |
| March 31, 2025 | -65.10M |
| December 31, 2024 | -168.70M |
| September 30, 2024 | 1.748B |
| June 30, 2024 | 375.80M |
| March 31, 2024 | -154.30M |
| December 31, 2023 | 115.80M |
| September 30, 2023 | -53.80M |
| June 30, 2023 | -76.60M |
| March 31, 2023 | -749.50M |
| December 31, 2022 | 1.784B |
| September 30, 2022 | -115.00M |
| June 30, 2022 | -82.10M |
| March 31, 2022 | -66.90M |
| December 31, 2021 | -219.10M |
| September 30, 2021 | -118.20M |
| June 30, 2021 | -16.80M |
| March 31, 2021 | 236.30M |
| December 31, 2020 | -22.30M |
| September 30, 2020 | -58.70M |
| June 30, 2020 | -74.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -145.60M |
| December 31, 2019 | -114.50M |
| September 30, 2019 | -176.90M |
| June 30, 2019 | -158.40M |
| March 31, 2019 | -75.60M |
| December 31, 2018 | -175.60M |
| September 30, 2018 | -302.10M |
| June 30, 2018 | -303.80M |
| March 31, 2018 | -428.90M |
| December 31, 2017 | -228.20M |
| September 30, 2017 | -126.90M |
| June 30, 2017 | -464.70M |
| March 31, 2017 | -164.10M |
| December 31, 2016 | -646.80M |
| September 30, 2016 | -5.781B |
| June 30, 2016 | -1.091B |
| March 31, 2016 | -160.00M |
| December 31, 2015 | -952.20M |
| September 30, 2015 | -372.60M |
| June 30, 2015 | -190.90M |
| March 31, 2015 | -87.50M |
| December 31, 2014 | -154.70M |
| September 30, 2014 | -321.20M |
| June 30, 2014 | -118.10M |
| March 31, 2014 | -201.20M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 2.106B |
| Eli Lilly & Co. | -15.40B |
| Merck & Co., Inc. | -5.602B |
| Bristol Myers Squibb Co. | -1.614B |
| Johnson & Johnson | -1.11B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 381.80M |
| Cash from Financing (Quarterly) | -1.243B |
| Free Cash Flow | 1.806B |
| Free Cash Flow Per Share (Quarterly) | 0.282 |
| Free Cash Flow to Equity (Quarterly) | 1.315B |
| Free Cash Flow to Firm (Quarterly) | 550.38M |
| Free Cash Flow Yield | 9.16% |